Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caligiuri

Showing results (711-720 of 1,066) with videos related to

Pageof 107
Sort By:
Plos One|June 23, 2011
LyGDI, a novel SHIP-interacting protein, is a negative regulator of FcγR-mediated phagocytosisPayal Mehta, Anne-Sophie Wavreille, Steven E Justiniano, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 31, 2002
Differentiation of Hdm2-mediated p53 ubiquitination and Hdm2 autoubiquitination activity by small molecular weight inhibitorsZhihong Lai, Tao Yang, Young B Kim, et al.
Inorganic Chemistry|April 25, 2022
Cytotoxicity of Alizarine versus Tetrabromocathecol Cyclometalated Pt(II) Theranostic Agents: A Combined Experimental and Computational InvestigationGloria Mazzone, Stefano Scoditti, Rossella Caligiuri, et al.
JHEP Reports : Innovation in Hepatology|March 7, 2022
Macrophage MerTK promotes profibrogenic cross-talk with hepatic stellate cells via soluble mediatorsMirella Pastore, Alessandra Caligiuri, Chiara Raggi, et al.
The Journal of Clinical Investigation|April 29, 1998
Ultra low dose interleukin-2 therapy promotes a type 1 cytokine profile in vivo in patients with AIDS and AIDS-associated malignanciesV P Khatri, T A Fehniger, R A Baiocchi, et al.
ACS Medicinal Chemistry Letters|April 19, 2019
Proof-of-Concept Multistage Biomimetic Liposomal DNA Origami Nanosystem for the Remote Loading of DoxorubicinStefano Palazzolo, Mohamad Hadla, Concetta Russo Spena, et al.
Nature Cancer|November 10, 2022
Specific targeting of glioblastoma with an oncolytic virus expressing a cetuximab-CCL5 fusion protein via innate and adaptive immunityLei Tian, Bo Xu, Yuqing Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2010
Chronic rejection triggers the development of an aggressive intragraft immune response through recapitulation of lymphoid organogenesisOlivier Thaunat, Natacha Patey, Giuseppina Caligiuri, et al.
Genes, Chromosomes & Cancer|January 13, 2005
Acute myeloid leukemia with deletion 9q within a noncomplex karyotype is associated with CEBPA loss-of-function mutationsStefan Fröhling, Richard F Schlenk, Jürgen Krauter, et al.
International Journal of Pharmaceutics|December 15, 2021
A carrier free delivery system of a monoacylglycerol lipase hydrophobic inhibitorMuhammad Adeel, Gloria Saorin, Giacomo Boccalon, et al.
Pageof 107

Showing results (711-720 of 1,066) with videos related to

Sort By:
Pageof 107
Plos One|June 23, 2011
LyGDI, a novel SHIP-interacting protein, is a negative regulator of FcγR-mediated phagocytosisPayal Mehta, Anne-Sophie Wavreille, Steven E Justiniano, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 31, 2002
Differentiation of Hdm2-mediated p53 ubiquitination and Hdm2 autoubiquitination activity by small molecular weight inhibitorsZhihong Lai, Tao Yang, Young B Kim, et al.
Inorganic Chemistry|April 25, 2022
Cytotoxicity of Alizarine versus Tetrabromocathecol Cyclometalated Pt(II) Theranostic Agents: A Combined Experimental and Computational InvestigationGloria Mazzone, Stefano Scoditti, Rossella Caligiuri, et al.
JHEP Reports : Innovation in Hepatology|March 7, 2022
Macrophage MerTK promotes profibrogenic cross-talk with hepatic stellate cells via soluble mediatorsMirella Pastore, Alessandra Caligiuri, Chiara Raggi, et al.
The Journal of Clinical Investigation|April 29, 1998
Ultra low dose interleukin-2 therapy promotes a type 1 cytokine profile in vivo in patients with AIDS and AIDS-associated malignanciesV P Khatri, T A Fehniger, R A Baiocchi, et al.
ACS Medicinal Chemistry Letters|April 19, 2019
Proof-of-Concept Multistage Biomimetic Liposomal DNA Origami Nanosystem for the Remote Loading of DoxorubicinStefano Palazzolo, Mohamad Hadla, Concetta Russo Spena, et al.
Nature Cancer|November 10, 2022
Specific targeting of glioblastoma with an oncolytic virus expressing a cetuximab-CCL5 fusion protein via innate and adaptive immunityLei Tian, Bo Xu, Yuqing Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2010
Chronic rejection triggers the development of an aggressive intragraft immune response through recapitulation of lymphoid organogenesisOlivier Thaunat, Natacha Patey, Giuseppina Caligiuri, et al.
Genes, Chromosomes & Cancer|January 13, 2005
Acute myeloid leukemia with deletion 9q within a noncomplex karyotype is associated with CEBPA loss-of-function mutationsStefan Fröhling, Richard F Schlenk, Jürgen Krauter, et al.
International Journal of Pharmaceutics|December 15, 2021
A carrier free delivery system of a monoacylglycerol lipase hydrophobic inhibitorMuhammad Adeel, Gloria Saorin, Giacomo Boccalon, et al.
Pageof 107